Table 2.
Tumor location | |||||
---|---|---|---|---|---|
RUL | RLL | LUD | LLD | LLL | |
n (%) | |||||
No. of patients with N2 | 79 (100) | 40 (100) | 41 (100) | 11 (100) | 24 (100) |
No. of patients with UMI | 76 (96) | 24 (60) | 41 (100) | 9 (82) | 10 (42) |
Patients with UMI | |||||
HI (–), SCI (–), LMI (–) | 44 (56) | 9 (23) | 22 (54) | 5 (45) | 2 (8) |
Clinical T1 | 14 (18) | 1 (4) | 5 (12) | 2 (18) | 1 (4) |
Clinical T2–4 | 30 (38) | 8 (21) | 17 (41) | 3 (27) | 1 (4) |
RUL right upper lobe, RLL right lower lobe, LUD left upper division, LLD left lingular division, LLL left lower lobe, UMI upper mediastinal involvement, HI hilar lymph node involvement, SCI subcarinal involvement, LMI lower mediastinal involvement